Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators. - Wikidata - wikimedia - TriplyDB

Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators.

Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators.

http://www.wikidata.org/entity/Q34221643

about

Somatostatin analogues for pancreatic surgery Somatostatin analogues for pancreatic surgery Somatostatin analogues for pancreatic surgery Intraductal papillary mucinous neoplasms of the pancreas: an updated experience Recent progress in pancreatic cancer Aberrant MicroRNA-155 expression is an early event in the multistep progression of pancreatic adenocarcinoma New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer Phase III trial of postoperative cisplatin, interferon alpha-2b, and 5-FU combined with external radiation treatment versus 5-FU alone for patients with resected pancreatic adenocarcinoma -- CapRI: study protocol [ISRCTN62866759]How Grim is Pancreatic Cancer?Pancreatic Cancer from Molecular Pathways to Treatment Opinion Chemoradiotherapy for locally advanced pancreatic cancer patients: is it still an open question?Prognostic value of lymph node metastases detected during surgical exploration for pancreatic or periampullary cancer: a systematic review and meta-analysis A systematic review of the role of periadventitial dissection of the superior mesenteric artery in affecting margin status after pancreatoduodenectomy for pancreatic adenocarcinoma State of the art biological therapies in pancreatic cancer Molecular detection of pancreatic neoplasia: Current status and future promise Management of borderline resectable pancreatic cancer Surgery for oligometastasis of pancreatic cancer Evolution and dynamics of pancreatic cancer progression Selection criteria in resectable pancreatic cancer: a biological and morphological approach Role of endoscopic ultrasound in the diagnosis of pancreatic cancer MiR-23a/-24-induced gene silencing results in mesothelial cell integration of pancreatic cancer DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer.SMAD4 gene mutations are associated with poor prognosis in pancreatic cancer.Pancreatic Cancer: 80 Years of Surgery-Percentage and Repetitions Biomarkers in pancreatic adenocarcinoma: current perspectives Re-evaluation of classical prognostic factors in resectable ductal adenocarcinoma of the pancreas New challenges in perioperative management of pancreatic cancer A thirteen-gene expression signature predicts survival of patients with pancreatic cancer and identifies new genes of interest.Preoperative capecitabine and concurrent radiation for borderline resectable pancreatic cancer.Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study re-evaluating the data of the Finnish Cancer Registry Primary resection versus neoadjuvant chemoradiation followed by resection for locally resectable or potentially resectable pancreatic carcinoma without distant metastasis. A multi-centre prospectively randomised phase II-study of the Interdisciplina Phase II clinical trial of induction chemotherapy with fixed dose rate gemcitabine and cisplatin followed by concurrent chemoradiotherapy with capecitabine for locally advanced pancreatic cancer.Lenalidomide in combination with gemcitabine as first-line treatment for patients with metastatic carcinoma of the pancreas: a Sarah Cannon Research Institute phase II trial.Synergetic anticancer effect of combined gemcitabine and photodynamic therapy on pancreatic cancer in vivo A phase I dose-escalation study of lenalidomide in combination with gemcitabine in patients with advanced pancreatic cancer.Re-adapting T cells for cancer therapy: from mouse models to clinical trials.Meta-analysis of randomized controlled trials on the effectiveness of somatostatin analogues for pancreatic surgery: a Cochrane review Pattern of breast cancer susceptibility gene 1 expression is a potential prognostic biomarker in resectable pancreatic ductal adenocarcinoma Prognosis and feasibility of en-bloc vascular resection in stage II pancreatic adenocarcinoma Prognostic significance of tumorigenic cells with mesenchymal features in pancreatic adenocarcinoma

P2860

Q24197947-2637BDF3-E78C-47C4-8345-DF32100DA67C Q24202647-99656485-263E-4AF5-8DB2-87F33CC3643D Q24239992-DDC1574E-DAF1-46C1-A1D1-BD441720338F Q24540094-5AD13852-DAE6-41FA-BA93-04C016F7483A Q24626346-A5F69087-B860-4D4E-9413-C406D08BBC28 Q24627680-0605E7D9-C7DE-4BCF-A8A2-6E2D0ABA3C5F Q24656132-922A691A-62F2-43FF-BF75-10E8A3D3B581 Q24792780-925A3176-8048-47F8-8574-E2F37C6066B3 Q26740598-ABD8119D-FD8C-4D78-B297-AD71F53A86DB Q26743482-97D61D6E-33E1-4F9E-B8C8-8BD56AC6287B Q26746031-B7F89E30-4387-421F-87D6-F3E972D50A2D Q26747108-30A8A783-D28A-4281-BDEF-413BB3A6FF2D Q26748880-7B1A06D5-B7D3-4C00-BCD2-F33E38F6621B Q26769941-EE7D7E07-F6A5-4C73-B770-BA41C3AE0EB6 Q26777379-29F85CD8-8FF1-4104-A927-F8FC147CCDFF Q26781445-C484E0CA-5838-44F1-8CB7-1422DC57EEBD Q26781546-C3DFA527-B569-43E6-905C-976EF6317D96 Q26849671-FC71ED74-AE15-40E7-B84A-8845646F4FC2 Q26859742-BB4FC738-7BCA-4EE5-99C5-7A9C1AE025F7 Q27027629-FAB11B3D-EAB1-4B1F-A491-B8F0190BBFAF Q27332271-95BAE3ED-2C1A-456C-A2CF-F5BB3020A616 Q27851466-15DA16F9-989D-48D7-B8B7-27658514CC6E Q27851475-24C5930C-2DC5-4479-943E-CDAC4A04EA11 Q28072182-D83CF382-3B67-40B5-9145-C167792B1CFA Q28072309-4FD62C05-43E1-4D30-9923-3269CBB22891 Q28075892-D80E9978-D6A4-4C0F-BA2B-FA70E4E92196 Q28082422-7FF309E5-8FD6-43A3-8368-A9DE407C3634 Q30410836-2F4FA92D-AA91-4969-9EFE-459710465B32 Q30452636-6D0F7AF1-1B64-48CC-9439-AEFEB7AB3F3C Q30982758-ED65B105-7B55-41F3-9DCA-0A8CAB4A33B7 Q33276956-36F78EF3-0E1C-45D8-A32F-6EA853430FA7 Q33402401-3F6EFF03-6993-4900-9CFF-A51452DA67A2 Q33405544-4652A5F9-DADE-4AA9-BEE7-69C5DD724FA4 Q33409922-606C4449-03FE-4E71-8CCE-579054BBB10B Q33421680-8C4785C0-AD94-48EB-8D86-1B9DEE1A5D61 Q33588711-B5302761-B882-41C3-908F-EDD5EC5E7217 Q33621862-7F6E7EBC-E7E2-44D6-9C7C-F2C073EFC9E2 Q33631833-D1EF9857-3278-44C6-B2C4-111FC9CA6A53 Q33688352-6D72A494-7669-4FCA-9BA3-DFB8F8E601FC Q33698761-795D2BEB-EF27-4307-A174-02B2E1ED31F6

P2860

Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators.

http://www.wikidata.org/entity/Q34221643

description

2000 nî lūn-bûn

@nan

2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Resected adenocarcinoma of the ...... es, and prognostic indicators.

@ast

Resected adenocarcinoma of the ...... es, and prognostic indicators.

@en

Resected adenocarcinoma of the ...... es, and prognostic indicators.

@nl

type

label

Resected adenocarcinoma of the ...... es, and prognostic indicators.

@ast

Resected adenocarcinoma of the ...... es, and prognostic indicators.

@en

Resected adenocarcinoma of the ...... es, and prognostic indicators.

@nl

prefLabel

Resected adenocarcinoma of the ...... es, and prognostic indicators.

@ast

Resected adenocarcinoma of the ...... es, and prognostic indicators.

@en

Resected adenocarcinoma of the ...... es, and prognostic indicators.

@nl

P1433

Q34221643-DF20D932-AF09-4E84-B7D6-F5E5B7C28A5D

P1476

Q34221643-61810843-35C2-4F4E-9F8D-8D912DD7EFB8

P2093

Q34221643-4903F5D1-6063-4010-B9C3-844DED380A1C

Q34221643-807F1B29-3B8C-41F8-A50F-B1781B11BB8C

Q34221643-895A1FAB-E44A-4FE1-BD53-25D3DB7B54EF

Q34221643-945F754F-BF2C-43AF-A623-AFB511A0D0F6

Q34221643-A937C5E3-1F29-4B19-A9C5-25EFD2613805

Q34221643-D9CE2587-6A26-44EE-B1DF-511BC2214868

Q34221643-E1E8AB44-0FB2-4C45-A724-C42F10C8B9F5

Q34221643-E2E56EE3-E652-49A3-AAF0-778FEEDDDC11

Q34221643-F3654826-D5D9-494D-9B5B-BDCA4ED168B6

Q34221643-FAA6D408-23F7-415F-BA30-820ECDC59A18

P2888

Q34221643-6E73308F-7498-41B8-A5A4-654C1BD19429

P304

Q34221643-DC34720A-4271-4234-B9D8-523B49C88E70

P31

Q34221643-7DB59BCC-C697-4AC7-B28E-D6AC2D4C8CCE

P356

Q34221643-CEC1D2FD-8A37-4F84-8BA7-A69F369B6238

P433

Q34221643-7D450FDE-5BA0-464C-865D-A3386727C211

P478

Q34221643-F0D3E0A8-0113-4259-89DC-FC617BD1F222

P577

Q34221643-9328E3E2-DE6E-4B8F-9C6E-6D4EBE23AA1C

P6179

Q34221643-CC6BF17F-D0A6-49E8-9255-9DEBD54242E0

P698

Q34221643-513BB1A3-D836-4327-B139-365DED9DE64A

P921

Q34221643-3826D6B7-1968-4F5E-956D-8CAB334460D4

Q34221643-586D93E0-059C-4F36-898F-A6BE61EA7090

Q34221643-8489AE89-EDF2-4FBE-8011-E07A531D245C

P356

S1091-255X(00)80105-5

P1433

Journal of Gastrointestinal Surgery

P1476

Resected adenocarcinoma of the ...... es, and prognostic indicators.

@en

P2093

Abrams RA

http://www.w3.org/2001/XMLSchema#string

Cameron JL

http://www.w3.org/2001/XMLSchema#string

Coleman J

http://www.w3.org/2001/XMLSchema#string

Hruban RH

http://www.w3.org/2001/XMLSchema#string

Kaushal S

http://www.w3.org/2001/XMLSchema#string

Koniaris L

http://www.w3.org/2001/XMLSchema#string

Lillemoe KD

http://www.w3.org/2001/XMLSchema#string

Sauter PK

http://www.w3.org/2001/XMLSchema#string

Sohn TA

http://www.w3.org/2001/XMLSchema#string

Yeo CJ

http://www.w3.org/2001/XMLSchema#string

P2888

s1091-255x(00)80105-5

P304

567-579

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S1091-255X(00)80105-5

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2000-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1048529586

http://www.w3.org/2001/XMLSchema#string

P698

11307091

http://www.w3.org/2001/XMLSchema#string

P921

Aizkuņģa dziedzeris